Use of gastrodia extract in preparation of a product for promoting secretion of adiponectin and / or inhibiting secretion of leptin
By preparing and applying Gastrodia elata extract, the problem of insufficient regulation of leptin and adiponectin secretion in existing technologies has been solved, achieving therapeutic effects in improving fat aging and metabolic diseases, and providing a safe and effective natural product option.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- BEIJING QINGYAN BOSHI HEALTH MANAGEMENT CO LTD
- Filing Date
- 2026-05-11
- Publication Date
- 2026-07-14
AI Technical Summary
Current technologies lack effective natural products to regulate the secretion of leptin and adiponectin, resulting in poor treatment outcomes for metabolic diseases such as adipose aging, obesity, diabetes, chronic inflammation, and atherosclerosis. Furthermore, existing drug treatments have side effects and are difficult to use long-term.
Gastrodia elata extract is prepared through reflux extraction, ultrafiltration and concentration processes to produce products that promote adiponectin secretion and/or inhibit leptin secretion, including oral and topical products, with concentrations ranging from 50 μg/mL to 400 μg/mL, for use in cosmetics and pharmaceuticals.
Gastrodia elata extract effectively inhibits leptin secretion, promotes adiponectin secretion, improves fat aging, and reduces the ratio of leptin to adiponectin, providing a safe and effective natural option with potential applications in alleviating fat aging and metabolic diseases.
Smart Images
Figure CN122376677A_ABST